The DOI matches its Crossref record.
CTX-M-5, a Novel Cefotaxime-Hydrolyzing β-Lactamase from an Outbreak of Salmonella typhimurium in Latvia
Open accessAbstract
At a children’s hospital in Riga, Latvia, isolates identified as Salmonella typhimurium were found to be resistant to expanded-spectrum cephalosporins. Two of the resistant strains were analyzed for the mechanism of cephalosporin resistance. Isoelectric focusing revealed a common β-lactamase with a pI of 8.8. In addition, one of the strains produced a pI 7.6 β-lactamase. A transconjugant producing only the pI 7.6 enzyme was susceptible to expanded-spectrum cephalosporins; therefore, this enzyme was most likely SHV-1. Transformants producing only the pI 8.8 β-lactamase were resistant to cefotaxime and aztreonam but were susceptible or intermediate to ceftazidime. A substrate profile determined spectrophotometrically with purified enzyme revealed potent activity against cefotaxime, with a relative k cat value of 95 (benzylpenicillin equal to 100). The enzyme showed lower relative k cat values for ceftazidime (3.3) and aztreonam (9.3). In addition, the enzyme was inhibited by clavulanate, sulbactam and tazobactam, with 50% inhibitory concentrations of 19, 100, and 3.4 nM, respectively. These results indicated the presence of an unusual extended-spectrum β-lactamase. The gene expressing the pI 8.8 β-lactamase was cloned. Nucleotide sequencing revealed a β-lactamase gene that differs from the gene encoding CTX-M-2, which also originated from S. typhimurium , by 11 nucleotides, 4 of which result in amino acid substitutions: Ala27Thr, Val230Gly, Glu254Ala, and Ile278Val. These results indicated the presence of a novel extended-spectrum β-lactamase, designated CTX-M-5, that specifically confers resistance to cefotaxime.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Self-citationGrowing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.08.002 · Cited by 758
Ceftriaxone-Resistant Salmonella Infection Acquired by a Child from Cattle
Fey, P. D., Safranek, T. J., Rupp, M. E., Dunne, E. F., Ribot, E., Iwen, P. C., Bradford, P. A., Angulo, F. J., & Hinrichs, S. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421703 · Cited by 540
Self-citationEdelstein, M., Pimkin, M., Palagin, I., Edelstein, I., & Stratchounski, L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3724-3732.2003 · Cited by 404
Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A., & the International Klebsiella Study Group (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3554-3560.2003 · Cited by 394
Eliopoulos, G. M., & Bush, K. (2001) · Clinical Infectious Diseases · doi:10.1086/319610 · Cited by 392
Saladin, M., Cao, V. T. B., Lambert, T., Donay, J.-L., Herrmann, J.-L., Ould-Hocine, Z., Verdet, C., Delisle, F., Philippon, A., & Arlet, G. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11126.x · Cited by 348
β-Lactamases of Kluyvera ascorbata , Probable Progenitors of Some Plasmid-Encoded CTX-M Types
Humeniuk, C., Arlet, G., Gautier, V., Grimont, P., Labia, R., & Philippon, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3045-3049.2002 · Cited by 338
Detection of β-lactamase-mediated resistance
Livermore, D. M., & Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.59 · Cited by 307
Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria
Zhao, W.-H., & Hu, Z.-Q. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.691460 · Cited by 302
Pitout, J. D. D., Hossain, A., & Hanson, N. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5715-5721.2004 · Cited by 298
Chiu, C.-H., Su, L.-H., & Chu, C. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.311-322.2004 · Cited by 297
Winokur, P. L., Brueggemann, A., DeSalvo, D. L., Hoffmann, L., Apley, M. D., Uhlenhopp, E. K., Pfaller, M. A., & Doern, G. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2777-2783.2000 · Cited by 287
CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes
Tzouvelekis, L. S., Tzelepi, E., Tassios, P. T., & Legakis, N. J. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00165-x · Cited by 275
Dunne, E. F. (2000) · JAMA · doi:10.1001/jama.284.24.3151 · Cited by 260
Metadata
- Authors
- Bradford, P. A., Yang, Y., Sahm, D., Grope, I., Gardovska, D., & Storch, G.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1998-08
- Volume
- 42
- Issue
- 8
- Pages
- 1980-1984
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2080486327
- Cited by
- 135
- References
- 0
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.